Fidelity Investments’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48.8K Buy
36,983
+7,128
+24% +$12.8K ﹤0.01% 4139
2025
Q4
$55.8K Buy
29,855
+11,279
+61% +$21.7K ﹤0.01% 4053
2025
Q3
$23.8K Sell
18,576
-547
-3% -$741 ﹤0.01% 4287
2025
Q2
$23.7K Buy
19,123
+10,377
+119% +$12K ﹤0.01% 4231
2025
Q1
$10.3K Sell
8,746
-13,907
-61% -$21.3K ﹤0.01% 4483
2024
Q4
$41.5K Sell
22,653
-385,498
-94% -$752K ﹤0.01% 3931
2024
Q3
$694K Buy
408,151
+353,092
+641% +$580K ﹤0.01% 2734
2024
Q2
$75.4K Sell
55,059
-797,848
-94% -$1.61M ﹤0.01% 3425
2024
Q1
$3.2M Sell
852,907
-2,872,147
-77% -$16.8M ﹤0.01% 2193
2023
Q4
$36.5M Sell
3,725,054
-897,866
-19% -$7.34M ﹤0.01% 1411
2023
Q3
$38.6M Buy
4,622,920
+892,145
+24% +$10.2M ﹤0.01% 1339
2023
Q2
$49.6M Sell
3,730,775
-637,392
-15% -$7.75M ﹤0.01% 1278
2023
Q1
$50.6M Buy
4,368,167
+4,217,484
+2,799% +$41.9M ﹤0.01% 1261
2022
Q4
$1.23M Sell
150,683
-37,617
-20% -$324K ﹤0.01% 2497
2022
Q3
$1.09M Sell
188,300
-1,032,423
-85% -$5.92M ﹤0.01% 2580
2022
Q2
$5.39M Sell
1,220,723
-258,710
-17% -$1.57M ﹤0.01% 2216
2022
Q1
$13.5M Sell
1,479,433
-312,858
-17% -$3.6M ﹤0.01% 1993
2021
Q4
$36.7M Buy
1,792,291
+1,528,880
+580% +$36.9M ﹤0.01% 1554
2021
Q3
$6.73M Buy
263,411
+73
+0% +$2.16K ﹤0.01% 2270
2021
Q2
$9.21M Sell
263,338
-2,712,824
-91% -$78.9M ﹤0.01% 2138
2021
Q1
$99.1M Buy
2,976,162
+2,975,982
+1,653,323% +$104M 0.01% 1071
2020
Q4
$5K Buy
180
+129
+253% +$2.19K ﹤0.01% 3450
2020
Q3
$1K Buy
+51
New +$294 ﹤0.01% 3591
2015
Q1
Sell
-60,000
Closed -$470K 2781
2014
Q4
$470K Buy
+60,000
New +$384K ﹤0.01% 2652

Other funds holding PACB